Adeno-Associated Virus Production of Soluble Tumor Necrosis Factor Receptor Neutralizes Tumor Necrosis Factor α and Reduces Arthritis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Human Gene Therapy

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303400750038525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple Applications For Replication‐Defective Herpes Simplex Virus Vectors

  2001cited by this paper
• Protection from experimental endotoxemia by a recombinant adeno‐associated virus encoding interleukin 10

  2001cited by this paper
• Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer1

  2000cited by this paper
• In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.

  2000cited by this paper
• Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts.

  2000cited by this paper
• Gene therapy that inhibits nuclear translocation of nuclear factor κB results in tumor necrosis factor α–induced apoptosis of human synovial fibroblasts

  2000cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases

  1999influential reference
• Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats.

  1999cited by this paper
• Inhibition of Tumor Necrosis Factor α Decreases Inflammation and Prolongs Adenovirus Gene Expression in Lung and Liver

  1998cited by this paper
• Recombinant Human Parvovirus B19 Vectors: Erythroid Cell-Specific Delivery and Expression of Transduced Genes

  1998cited by this paper
• Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.

  1998cited by this paper
• Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.

  1998cited by this paper
• High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus

  1998cited by this paper
• Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver.

  1998cited by this paper
• Getting genes into human synovium.

  1997cited by this paper
• Characterization of a SV40-transformed rheumatoid synovial fibroblast cell line which retains genotypic expression patterns: A model for evaluation of anti-arthritic agents

  1997cited by this paper
• Persistence in muscle of an adenoviral vector that lacks all viral genes.

  1997cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition.

  1997cited by this paper
• Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

  1997cited by this paper
• A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling

  1997cited by this paper
• Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

  1997cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• The Role of Cytokines in Rheumatoid Arthritis

  1996cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996cited by this paper
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis

  1995cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

  1995cited by this paper
• Current protocols in human genetics

  1994cited by this paper
• Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram- negative sepsis

  1994cited by this paper
• The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

  1993cited by this paper
• Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

  1991cited by this paper
• Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

  1991influential reference
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper

• Genetically Modified Mesenchymal Stromal Cells in Cartilage Regeneration

  2023cites this paper
• Potential Gene Therapy Options for Early OA

  2021cites this paper
• Scaffold-Mediated Gene Delivery for Osteochondral Repair

  2020cites this paper
• Gene Therapy and Immunosenescence

  2019cites this paper
• Gene Delivery to Joints by Intra-Articular Injection

  2018cites this paper
• Gene Therapy in Cartilage Repair and Regeneration

  2018cites this paper
• 6 Gene Therapy for Human Osteoarthritis

  2018cites this paper
• Gene therapy for human osteoarthritis: principles and clinical translation

  2016cites this paper
• Gene therapy of arthritis

  2016cites this paper
• Gene Transfer Strategies to Promote Chondrogenesis and Cartilage Regeneration

  2015cites this paper
• Pervasive axonal transport deficits in multiple sclerosis models.

  2014cites this paper
• development of hemophilic synovitis in the absence of circulating factor IX Intra-articular factor IX protein or gene replacement protects against

  2013cites this paper
• Modèle d’arthrite au collagène chez le rat : le transfert du gène codant pour l’ostéoprotégérine via des virus adeno-associated protège contre la destruction articulaire

  2012cites this paper
• scAAV-Mediated Gene Transfer of Interleukin 1-Receptor Antagonist to Synovium and Articular Cartilage in Large Mammalian Joints

  2012cites this paper
• Gene Therapy for Human Osteoarthritis

  2012cites this paper
• Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model.

  2012cites this paper
• Gene Therapy for Rheumatoid Arthritis

  2011cites this paper
• Therapeutic gene transfer for rheumatoid arthritis.

  2011cites this paper
• Integrating Viral Vectors for Gene Modifications

  2011cites this paper
• Clinical potential and challenges of using genetically modified cells for articular cartilage repair

  2011cites this paper
• Orthopaedic gene therapy using recombinant adeno-associated virus vectors.

  2011cites this paper
• Gene Therapy for Cartilage Repair

  2011cites this paper
• Local immunomodulatory gene therapy for Sjögren’s syndrome

  2010cites this paper
• Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritis

  2010cites this paper
• Genetic modification of mesenchymal stem cells for cartilage repair

  2010cites this paper
• Development of AAV vectors for the therapy of autoimmune and inflammatory diseases

  2010cites this paper
• Gene therapy for arthritis

  2010cites this paper
• Gene therapy in articular cartilage repair

  2010cites this paper
• Optimizing adeno-associated virus as a gene therapy vector for treating arthritis

  2009cites this paper
• Intra‐articular gene delivery and expression of interleukin‐1Ra mediated by self‐complementary adeno‐associated virus

  2009cites this paper
• Gene Therapy and Immune Senescence

  2009cites this paper
• Perspectives on the use of gene therapy for chronic joint diseases.

  2008cites this paper
• IGF-1 gene therapy to protect articular cartilage in a rat model of joint damage

  2008cites this paper
• Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren ' s syndrome

  2008cites this paper
• Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

  2008cites this paper
• Gentherapeutische Ansätze bei rheumatoider Arthritis

  2008cites this paper
• Gene therapy for arthritis

  2008cites this paper
• Concepts in genetic medicine

  2008cites this paper
• The use of recombinant adeno-associated virus for skeletal gene therapy.

  2007cites this paper
• Gene therapy for articular cartilage repair

  2007cites this paper
• Synoviocyte Infection with Adeno-Associated Virus (AAV) Is Neutralized by Human Synovial Fluid from Arthritis Patients and Depends on AAV Serotype

  2007cites this paper
• Application techniques de thérapie aux maladies ostéo-articulaires

  2007cites this paper
• Application des techniques de thérapie génique aux maladies ostéo-articulaires

  2007cites this paper
• Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases.

  2007cites this paper
• Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent

  2007cites this paper
• Gene therapy for rheumatoid arthritis

  2007cites this paper
• Inflammation‐inducible anti‐TNF gene expression mediated by intra‐articular injection of serotype 5 adeno‐associated virus reduces arthritis

  2007cites this paper
• Traitements ciblés anti-cytokines dans l’arthrose

  2006cites this paper
• Gene therapy for patients with rheumatoid arthritis.

  2006cites this paper
• Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.

  2006cites this paper
• Gene therapeutic approaches-transfer in vivo.

  2006cites this paper
• AAV-mediated gene transfer to synovium: enhancing effects of inflammatory cytokines and proteasome inhibitors

  2006cites this paper
• TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.

  2006cites this paper
• Inflammatory cytokine regulation of transgene expression in human fibroblast-like synoviocytes infected with adeno-associated virus.

  2006cites this paper
• Technology Insight: gene transfer and the design of novel treatments for rheumatoid arthritis

  2006cites this paper
• Complete Prevention of Atherosclerosis in ApoE-Deficient Mice by Hepatic Human ApoE Gene Transfer With Adeno-Associated Virus Serotypes 7 and 8

  2006cites this paper
• Gene therapy for arthritis: what next?

  2006cites this paper
• Treatment of human disease by adeno-associated viral gene transfer

  2006cites this paper
• Gene therapy works in animal models of rheumatoid arthritis so what!

  2006cites this paper
• Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome.

  2005cites this paper
• Gene therapy for cartilage defects

  2005cites this paper
• Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice.

  2005cites this paper
• Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints

  2005cites this paper
• Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy

  2005cites this paper
• Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo.

  2005cites this paper
• Ingénierie tissulaire du cartilage : état des lieux et perspectives

  2005cites this paper
• La thérapie génique au service de la polyarthrite rhumatoïde

  2005cites this paper
• Gene Therapy Approaches for Autoimmune Diseases of the Central Nervous System and Other Tissues

  2005cites this paper
• Thérapie génique non virale de variants du gène du récepteur soluble de type I du TNF-alpha humain. Application à différents modèles de pathologies inflammatoires

  2005cites this paper
• Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium: implications for arthritis therapy

  2004cites this paper
• Gene therapies for osteoarthritis

  2004cites this paper
• Gene Therapy of Collagen-Induced Arthritis by Electrotransfer of Human Tumor Necrosis Factor-α Soluble Receptor I Variants

  2004cites this paper
• Therapeutic gene transfer for rheumatoid arthritis La terapia genica nell'artrite reumatoide

  2004cites this paper
• Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?

  2004cites this paper
• A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL

  2004cites this paper
• Gene transfer as a future therapy for rheumatoid arthritis

  2003influential citation
• Möglichkeiten der Gentherapie

  2003cites this paper
• Biology and pathology of the temporomandibular joint: is there an animal model to study this affliction?

  2003cites this paper
• GENE THERAPY FOR RHEUMATOID ARTHRITIS Lessons from Animal Models , Including Studies on Interleukin-4 , Interleukin-10 , and Interleukin-1 Receptor Antagonist as Potential Disease Modulators

  2003cites this paper
• CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis.

  2003cites this paper
• Local Adeno-Associated Virus-Mediated Interleukin 10 Gene Transfer Has Disease-Modifying Effects in a Murine Model of Sjögren's Syndrome

  2003cites this paper
• Vectors for gene therapy of joint disorders.

  2003cites this paper
• Vectors for the treatment of autoimmune disease

  2003cites this paper
• Advances in vector-mediated gene transfer.

  2003cites this paper
• Recombinant Adeno-Associated Virus Vectors Efficiently and Persistently Transduce Chondrocytes in Normal and Osteoarthritic Human Articular Cartilage

  2003cites this paper
• Les outils de la thérapie génique des maladies articulaires

  2003cites this paper
• Bioingénierie du cartilage et arthrose expérimentale

  2003cites this paper
• Gene therapy in orthopaedic surgery.

  2002cites this paper
• Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.

  2002cites this paper
• High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets

  2002cites this paper
• Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators.

  2002cites this paper
• The potential for gene therapy in the treatment of autoimmune disease.

  2002cites this paper
• Addition of Six-His-Tagged Peptide to the C Terminus of Adeno-Associated Virus VP3 Does Not Affect Viral Tropism or Production

  2002cites this paper
• Chapter 14 – Novel Methods to Eliminate the Immune Response to Adenovirus Gene Therapy

  2002cites this paper
• Depletion of Collagen II-Reactive T Cells and Blocking of B Cell Activation Prevents Collagen II-Induced Arthritis in DBA/1j Mice

  2002cites this paper
• C3-Tat/HIV-regulated intraarticular human interleukin-1 receptor antagonist gene therapy results in efficient inhibition of collagen-induced arthritis superior to cytomegalovirus-regulated expression of the same transgene.

  2002cites this paper
• Collagen II-Induced Arthritis in DBA / 1 j Mice Blocking of B Cell Activation Prevents Depletion of Collagen II-Reactive T Cells and and

  2002cites this paper
• GENE THERAPY FOR

  2002cites this paper
• Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver

  2002cites this paper
• Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis.

  2002cites this paper